R21 Roche: 3-Way Tau Tracers in AD

Clinical trial NCT05464368 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05464368
Sponsor: Washington University School of Medicine
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2023-02-01
Primary completion: 2027-06-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.